BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3840
+0.0089 (2.37%)
At close: Jun 27, 2025, 4:00 PM
0.4000
+0.0160 (4.17%)
After-hours: Jun 27, 2025, 7:41 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $22.43 million as of June 27, 2025. Its market cap has decreased by -70.68% in one year.
Market Cap
22.43M
Enterprise Value
-9.38M
1-Year Change
-70.68%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $22.43M, a decrease of -96.12%. That is a compound annual growth rate of -51.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 23.28M | -32.14% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.75B |
| Johnson & Johnson | 366.76B |
| AbbVie | 326.98B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 278.56B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.02B |
| AstraZeneca | 215.99B |